Common name |
B-hCD155 MC38 | Catalog number | 310697 |
Aliases |
PVR, HVED, NECL5, Necl-5, PVS, TAGE4
|
Disease | Colon carcinoma |
Organism |
Mouse |
Strain | C57BL/6 |
Tissue types | Colon | Tissue | Colon |
Description
The mouse Cd155 gene was replaced by human CD155 coding sequence in B-hCD155 MC38 cells. Human CD155 is highly expressed on the surface of B-hCD155 MC38 cells.
Application
Targeting strategy
Gene targeting strategy for B-hCD155 MC38 cells. The exogenous promoter and human CD155 coding sequence was inserted to replace part of murine exon 2-3. The insertion disrupts the endogenous murine Cd155 gene, resulting in a non-functional transcript.
Protein expression analysis
CD155 expression analysis in B-hCD155 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hCD155 MC38 cultures were stained with species-specific anti-CD155 antibody. Human CD155 was detected on the surface of B-hCD155 MC38 cells but not wild-type MC38 cells. The 3-B8 clone of B-hCD155 MC38 cells was used for in vivo experiments.
Tumor growth curve & Body weight changes
Subcutaneous homograft tumor growth of B-hCD155 MC38 cells. B-hCD155 MC38 cells (1x107) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hTIGIT mice (female, 7-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD155 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.
Protein expression analysis of tumor cells